anti-SARS-CoV-2 convalescent plasma
/ OrthoSera
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 25, 2021
Anti COVID-19 Convalescent Plasma Therapy
(clinicaltrials.gov)
- P1; N=20; Recruiting; Sponsor: Orthosera Kft.; Not yet recruiting ➔ Recruiting; Trial completion date: Apr 2021 ➔ Sep 2021; Trial primary completion date: Jun 2020 ➔ Jun 2021
Enrollment open • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease
April 14, 2020
Anti COVID-19 Convalescent Plasma Therapy
(clinicaltrials.gov)
- P1; N=20; Not yet recruiting; Sponsor: Orthosera Kft.
New P1 trial • Infectious Disease • Novel Coronavirus Disease
1 to 2
Of
2
Go to page
1